Amiodarone

Pharmacological Intervention to Prevent NOAF After TAVR

Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm

Shortening Duration of Antiarrhythmic Medication for SVT in Infants

Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery

Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With Rapid Ventricular Response

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery

Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery

Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients

MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care

Repeated Amiodarone Dosing In Cardiac surgicaL Procedures

Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter

Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation

Prevention of Post-Operative Cardiac Arrhythmias

Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms

Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease

AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia

INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events

Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery